Table 1.
Sample Characteristics (n = 11,714)
| General Characteristics | % | N |
|---|---|---|
| Child gender (female) | 49 | 5,803 |
| Child race/ethnicity | ||
| Hispanic | 19 | 4,258 |
| Non-Latino Black | 15 | 3,505 |
| Non-Hispanic other | 7 | 621 |
| Non-Hispanic White | 59 | 3,330 |
| Child age (years) | ||
| <5 | 24 | 3,271 |
| 5–11 | 40 | 4,074 |
| 12–18 | 37 | 4,369 |
| Income as % FPL | ||
| 0–99 | 22 | 3,798 |
| 100–199 | 23 | 3,137 |
| 200–399 | 30 | 2,990 |
| ≥400 | 25 | 1,789 |
| Health insurance | ||
| Uninsured | 11 | 1,670 |
| Private | 56 | 4,945 |
| Medicaid/SCHIP | 22 | 3,525 |
| Other (Military, Indian Health Service, other*) | 10 | 1,502 |
| Survey year | ||
| 2003–2004 | 33 | 4,022 |
| 2005–2006 | 33 | 4,256 |
| 2007–2008 | 33 | 3,436 |
| Asthma-related characteristics | ||
| Has a current diagnosis of asthma | 10 | 1,214 |
| Wheeze in past year | 13 | 1,540 |
| Sleep disturbance | ||
| Never | 93 | 10,803 |
| <1 per week | 4 | 480 |
| At least 1 per week | 3 | 431 |
| Activity Limitation, any | 6 | 679 |
| Currently taking ICS | 2 | 290 |
| Currently taking other long-term controller medication* | 3 | 245 |
| Currently taking short-acting bronchodilator | 5 | 577 |
| Asthma symptom severity | ||
| No symptoms | 87 | 10,174 |
| Intermittent symptoms | 5 | 562 |
| Persistent symptoms | 8 | 978 |
Notes.
*
Includes long-acting bronchodilators and immunomodulators.
ICS, inhaled corticosteroids; FPL, federal poverty level.